ELFABRIO 5 mg/2.5mL
pegunigalsidase alfa · INJECTION, SOLUTION, CONCENTRATE · Chiesi USA, Inc.
ELFABRIO is a injection, solution, concentrate containing pegunigalsidase alfa at 5 mg/2.5mL, taken intravenous. Manufactured by Chiesi USA, Inc..
Key Facts
- Brand Name
- ELFABRIO
- Generic Name
- pegunigalsidase alfa
- NDC Code (Product)
10122-165- Manufacturer
- Chiesi USA, Inc.
- Strength
- 5 mg/2.5mL
- Dosage Form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761161
- Drug Class
- Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC]
- Marketing Start
- 05/23/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is ELFABRIO used for?
ELFABRIO contains pegunigalsidase alfa. It is a injection, solution, concentrate taken intravenous. Consult your doctor for specific uses.
Is ELFABRIO a controlled substance?
ELFABRIO is not classified as a controlled substance by the DEA.
What is the generic name for ELFABRIO?
The generic name for ELFABRIO is pegunigalsidase alfa. There are no other listed brand versions of pegunigalsidase alfa.
What is the NDC code for ELFABRIO 5 mg/2.5mL?
The NDC (National Drug Code) for ELFABRIO 5 mg/2.5mL is 10122-165, listed by Chiesi USA, Inc..
Other ELFABRIO Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)